GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2003 | 06-2003 | 03-2003 | 12-2002 | 09-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -571 | -427 | -149 | -822 | -657 |
| Depreciation Amortization | 141 | 92 | 45 | 282 | 204 |
| Accounts receivable | -77 | -32 | -66 | -39 | -47 |
| Accounts payable and accrued liabilities | 115 | 254 | 71 | -268 | -284 |
| Other Working Capital | 109 | 72 | 28 | -468 | -581 |
| Other Operating Activity | -46 | -130 | -13 | 307 | 331 |
| Operating Cash Flow | $-329 | $-171 | $-84 | $-1,008 | $-1,034 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10 | -10 | -8 | -6 | N/A |
| Sale Of Investment | 62 | 62 | 62 | N/A | N/A |
| Other Investing Activity | -139 | -131 | -22 | -174 | -113 |
| Investing Cash Flow | $-87 | $-79 | $32 | $-180 | $-113 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 234 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 1,406 | 1,412 |
| Financing Cash Flow | $234 | $N/A | $N/A | $1,406 | $1,412 |
| Exchange Rate Effect | -4 | -2 | -1 | -15 | N/A |
| Beginning Cash Position | 424 | 424 | 424 | 221 | 221 |
| End Cash Position | 238 | 172 | 371 | 424 | 486 |
| Net Cash Flow | $-186 | $-252 | $-53 | $203 | $265 |
| Free Cash Flow | |||||
| Operating Cash Flow | -329 | -171 | -84 | -1,008 | -1,034 |
| Capital Expenditure | -10 | -10 | -8 | -6 | N/A |
| Free Cash Flow | -339 | -181 | -92 | -1,014 | -1,034 |